Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02048943
Title Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

Advanced Solid Tumor

pancreatic cancer

Therapies

Dovitinib + Gemcitabine + Nab-paclitaxel

Nab-paclitaxel

Dovitinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.